Gastric/Esophageal cancer

Showing 9 of 0 results

• Real-world biomarker testing rates, targeted therapy use, and clinical outcomes in patients with advanced gastric or GEJ cancer in the United States

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Precision medicine
  • Gastric/Esophageal cancer
• Case study: Early-onset cancer trends in Japan and the US
  • Case study
  • Gastric/Esophageal cancer
  • Colorectal cancer
• Exposure to US cancer drugs with lack of confirmed benefit after US Food and Drug Administration accelerated approval

  JAMA Oncology

  • Real-world evidence
  • Publication summary
  • Publications
  • Unmet need
  • Hepatocellular carcinoma
  • Gastric/Esophageal cancer
  • Breast cancer
  • Small cell lung cancer
• Analysis of a real-world progression variable and related endpoints for patients with five different cancer types

  Advances in Therapy

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • Renal cell carcinoma
  • Melanoma
  • Gastric/Esophageal cancer
  • Breast cancer
  • Small cell lung cancer
• ERBB2 copy number (CN) as a quantitative biomarker for real-world (RW) outcomes to anti-HER2 therapy in advanced gastroesophageal adenocarcinoma (adv GEA)

  ASCO Annual Meeting

  • Publications
  • Drug discovery
  • Gastric/Esophageal cancer
• Adherence to and determinants of guideline-recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: insights from routine practice

  Cancer

  • Publications
  • Treatment patterns
  • Gastric/Esophageal cancer
• Association of real-world agreement between HER2 expression and ERBB2 amplification with trastuzumab therapy benefit in advanced gastric/esophageal (adv GE) cancer patients (pts)

  ASCO GI Symposium

  • Publications
  • Drug discovery
  • Gastric/Esophageal cancer
• Organ dysfunction and clinical outcomes in patients treated with immune checkpoint inhibitors

  ASCO Annual Meeting

  • Publications
  • Unmet need
  • Renal cell carcinoma
  • Melanoma
  • Gastric/Esophageal cancer
  • Non-small cell lung cancer
  • Head and neck cancer
• Chemotherapy use near end of life (EOL): measuring real world benchmarks

  ASCO Quality Care Symposium

  • Publications
  • Treatment patterns
  • Renal cell carcinoma
  • Gastric/Esophageal cancer
  • Breast cancer
  • Colorectal cancer
  • Small cell lung cancer
  • Non-small cell lung cancer
  • Pancreatic cancer